SCHEMBL8812232

SCHEMBL8812232

CC(C)([SiH2][NH])C(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.41
LMNA P02545 1/20 0.37
HRH1 P35367 4/20 0.34
HTR2A P28223 2/20 0.34
SLC6A3 Q01959 2/20 0.34
SLC6A4 P31645 2/20 0.34
AOC3 Q16853 1/20 0.34
CACNA1F O60840 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
ADRA2B P18089 1/20 0.34
CHRM3 P20309 1/20 0.34
ADRA1A P35348 1/20 0.34
OPRK1 P41145 1/20 0.34
CACNA1D Q01668 1/20 0.34
KCNH2 Q12809 1/20 0.34
CACNA1S Q13698 1/20 0.34
CACNA1C Q13936 1/20 0.34
SCN5A Q14524 1/20 0.34
MIF P14174 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2480309 0.77 RIPK1 (0.41) RIPK1LMNAHRH1HTR2ASLC6A3
SCHEMBL704603 0.77 RIPK1 (0.41) RIPK1LMNAHRH1HTR2ASLC6A3
SCHEMBL187205 0.77 RIPK1 (0.41) RIPK1LMNAHRH1HTR2ASLC6A3
SCHEMBL708031 0.77 RIPK1 (0.41) RIPK1LMNAHRH1HTR2ASLC6A3
SCHEMBL9452316 0.76 RIPK1 (0.39) RIPK1LMNAHRH1HTR2ASLC6A3
SCHEMBL343426 0.73 LMNA (0.41) RIPK1LMNAHRH1HTR2ASLC6A3
SCHEMBL5029899 0.72 RIPK1 (0.43) RIPK1LMNAHRH1HTR2ASLC6A3
SCHEMBL705924 0.71 RIPK1 (0.40) RIPK1LMNAHRH1SLC6A3SLC6A4
SCHEMBL704144 0.71 ATM (0.39) RIPK1LMNAHRH1HTR2ASLC6A3
SCHEMBL708398 0.70 LMNA (0.39) RIPK1LMNAHRH1HTR2ASLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5691319-A ANTICARCINOGENIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-11-25 US disclosed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed